Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of combined PDT and SDT antimicrobial efficacy on human skin
2023-000126-29Phase 2Completed
- Sponsor
- Staatliches Gesundheitsamt
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methylene blue in bacterial infections of skin and subcutaneous tissue (SSTI) and Not applicable, sponsored by Staatliches Gesundheitsamt. Primary endpoint: Termination of application of the substance with PDT and SDT. Started Jan 2023; status: completed.
02
Drugs
methylene blue
03
Conditions
bacterial infections of skin and subcutaneous tissue (SSTI)Not applicable
Beyond the preview
Go deeper on 2023-000126-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-000126-29.